Gossamer Bio Inc. (GOSS) Misses Q3 EPS by 2c; Reports Cash and Cash Equivalents of $366.0M

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.80), $0.02 worse than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg